Education
About Us
Working with TipRanks
Follow Us
CARE Ratings Ltd (IN:CARERATING)
:CARERATING
Top Page
CARE Ratings Ltd
(CARERATING)
Rating:65Neutral
Price Target:
₹1,852.00
▲(11.25% Upside)
CARE Ratings Ltd (CARERATING) vs. iShares MSCI India ETF (INDA)
Market Cap
₹49.14B
Dividend Yield1.1%
Average Volume (3M)3.65K
Price to Earnings (P/E)34.5
Beta (1Y)0.49
Revenue Growth21.24%
EPS Growth36.98%
CountryIN
Employees563
SectorFinancial
Sector Strength70
IndustryFinancial - Data & Stock Exchanges
Share Statistics
EPS (TTM)8.61
Shares Outstanding29,974,514
10 Day Avg. Volume3,434
30 Day Avg. Volume3,650
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,852.00Price Target Upside11.25% Upside
Rating ConsensusHold
Number of Analyst Covering1
CARE Ratings Ltd Business Overview & Revenue Model
Company DescriptionCARE Ratings Ltd (CARERATING) is a prominent credit rating agency in India, providing a wide range of rating and grading services across various sectors. Established to offer reliable credit risk assessment services, the company evaluates the creditworthiness of entities and instruments. Its core services include rating financial instruments, such as bonds and loans, as well as providing insights and research on economic and financial sectors.
How the Company Makes MoneyCARE Ratings Ltd generates revenue primarily through fees charged for its credit rating services. These services are availed by corporations, financial institutions, and government bodies seeking to issue debt instruments like bonds or obtain loans. The company earns fees based on the complexity, size, and type of the financial instrument being rated. Besides credit ratings, CARE Ratings also offers industry research and risk management advisory services, which contribute to its revenue. Strategic partnerships with financial institutions and regulatory bodies further enhance its service offerings and market reach, thereby contributing to its financial performance.
CARE Ratings Ltd Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.02B | 3.32B | 2.79B | 2.47B | 2.39B |
| Gross Profit | 2.13B | 1.82B | 1.45B | 1.35B | 1.18B |
| EBITDA | 1.55B | 1.59B | 1.37B | 1.07B | 1.27B |
| Net Income | 1.37B | 1.01B | 835.29M | 751.08M | 895.16M |
Balance Sheet | |||||
| Total Assets | 9.58B | 8.42B | 7.70B | 7.27B | 6.72B |
| Cash, Cash Equivalents and Short-Term Investments | 6.47B | 6.23B | 5.65B | 5.22B | 4.86B |
| Total Debt | 237.69M | 195.54M | 174.78M | 89.13M | 72.26M |
| Total Liabilities | 1.42B | 1.17B | 905.77M | 745.98M | 787.34M |
| Stockholders Equity | 8.06B | 7.17B | 6.72B | 6.47B | 5.89B |
Cash Flow | |||||
| Free Cash Flow | 1.08B | 817.10M | 707.36M | 490.20M | 816.84M |
| Operating Cash Flow | 1.23B | 908.82M | 822.42M | 680.03M | 861.74M |
| Investing Cash Flow | -584.28M | -390.66M | 128.80M | -273.18M | -377.19M |
| Financing Cash Flow | -539.96M | -629.55M | -633.31M | -351.38M | -433.64M |
CARE Ratings Ltd Technical Analysis
Neutral
1664.70
Price Trends
1779.07
Negative
1557.72
Positive
1433.13
Positive
Market Momentum
-36.20
Positive
42.16
Neutral
46.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CARERATING, the sentiment is Neutral. The current price of 1664.7 is below the 20-day moving average (MA) of 1717.42, below the 50-day MA of 1779.07, and above the 200-day MA of 1433.13, indicating a neutral trend. The MACD of -36.20 indicates Positive momentum. The RSI at 42.16 is Neutral, neither overbought nor oversold. The STOCH value of 46.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:CARERATING.
CARE Ratings Ltd Peers Comparison
Overall Rating
UnderperformOutperform
Sector (69)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | CHF15.52B | 15.81 | 13.20% | 3.77% | 0.77% | 28.86% | |
67 Neutral | ₹58.89B | 33.18 | 0.99% | 10.80% | 21.15% | ||
65 Neutral | ₹49.14B | 34.47 | 1.10% | 21.24% | 36.98% | ||
61 Neutral | ₹373.99B | 51.39 | 1.13% | 6.03% | 11.92% |
* Financial Sector Average
Performance Comparison
IN:CARERATING
CARE Ratings Ltd
1,664.70
708.28
74.06%
IN:CRISIL
CRISIL Limited
5,202.10
817.22
18.64%
IN:ICRA
ICRA Limited
6,183.50
455.05
7.94%
CARE Ratings Ltd Corporate Events
CARE Ratings Expands Share Capital with Employee Stock Option Allotment
Aug 5, 2025
CARE Ratings Limited has announced the allotment of 16,066 equity shares to its employees under the CARE Employee Stock Option Scheme 2020, following approval by the Nomination and Remuneration Committee. This allotment will increase the company’s paid-up share capital, reflecting its commitment to employee engagement and retention through stock-based incentives.
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.